During the past decade, CRC Medical Department IV conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CRC Medical Department IV" are "Diabetes Mellitus Type 2" (1 trials), "Essential Hypertension" (1 trials) and "Hypertension" (1 trials). Many other conditions were trialed in "CRC Medical Department IV" in a lesser frequency.

Most popular intervention types in "CRC Medical Department IV" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Pioglitazone" (1 trials), "Placebo" (1 trials), "eplerenone" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "CRC Medical Department IV" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "CRC Medical Department IV". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in CRC Medical Department IV, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CRC Medical Department IV, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".